Acupuncture for Women's Health Conditions
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT00090389 |
Recruitment Status
:
Completed
First Posted
: August 26, 2004
Last Update Posted
: January 25, 2008
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Ovarian Neoplasms Endometriosis Pelvic Pain Uterine Neoplasms | Procedure: Chinese Acupuncture | Phase 1 |
Study Type : | Interventional (Clinical Trial) |
Enrollment : | 50 participants |
Allocation: | Randomized |
Intervention Model: | Parallel Assignment |
Masking: | Single |
Primary Purpose: | Treatment |
Official Title: | New England School of Acupuncture (NESA) Acupuncture Research Collaborative |
Study Start Date : | January 2005 |
Actual Primary Completion Date : | May 2007 |
Actual Study Completion Date : | May 2007 |


Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years and older (Adult, Senior) |
Sexes Eligible for Study: | Female |
Accepts Healthy Volunteers: | No |
Inclusion Criteria for Study 1:
- Newly diagnosed ovarian cancer; primary peritoneal cancer; papillary serous cancer of the endometrium; or mixed mesodermal tumor of the uterus, ovary, or fallopian tube
- Currently undergoing chemotherapy
- Meet certain laboratory test requirements
Inclusion Criteria for Study 2:
Currently closed to recruitment
- Diagnosed with endometriosis or unspecified pelvic pain
Exclusion Criteria for Studies 1 and 2:
- Use of white blood cell boosters
- Prior radiotherapy with the exception of whole-breast irradiation for breast cancer
- Prior myelotoxic chemotherapy
- History of symptomatic cardiac or psychiatric disorder
- Use of a pacemaker
- Use of herbs or herbal supplements
- Prior use of acupuncture
- Enrollment in other research studies

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00090389
United States, Massachusetts | |
Dana Farber Cancer Institute | |
Boston, Massachusetts, United States, 02115 |
Principal Investigator: | Peter Wayne, PhD | New England School of Acupuncture |
ClinicalTrials.gov Identifier: | NCT00090389 History of Changes |
Other Study ID Numbers: |
U19AT002022 ( U.S. NIH Grant/Contract ) |
First Posted: | August 26, 2004 Key Record Dates |
Last Update Posted: | January 25, 2008 |
Last Verified: | January 2008 |
Keywords provided by National Center for Complementary and Integrative Health (NCCIH):
Acupuncture Medicine, Chinese Traditional |
Additional relevant MeSH terms:
Genital Diseases, Female Genital Neoplasms, Female Neoplasms Endometriosis Pelvic Pain Ovarian Neoplasms Uterine Neoplasms Pain Neurologic Manifestations |
Signs and Symptoms Endocrine Gland Neoplasms Neoplasms by Site Ovarian Diseases Adnexal Diseases Urogenital Neoplasms Endocrine System Diseases Gonadal Disorders Uterine Diseases |